Vascular smooth muscle cell in atherosclerosis

Acta Physiologica

Volumn 214, Issue 1, 2015, Pages 33-50

  Chistiakov, D A ^a,b   Orekhov, A N ^c,d,e   Bobryshev, Y V ^c,f,g  

^a Scientific Center of Children's Health   (Russian Federation)

^b Mount Sinai Comprehensive Cancer Center   (United States)

^c Skolkovo Innovation Center   (Russian Federation)

^d INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^e MOSCOW STATE UNIVERSITY   (Russian Federation)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Arteries; Artery wall; Atherogenesis; Atherosclerosis; Vascular smooth muscle cells

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN;

APOPTOSIS; ARTERY CALCIFICATION; ARTERY INTIMA; ATHEROGENESIS; ATHEROSCLEROSIS; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CHRONIC INFLAMMATION; EXTRACELLULAR MATRIX; HEART HEMODYNAMICS; HUMAN; NONHUMAN; PHENOTYPE; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; REVIEW; SHEAR STRESS; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; ANIMAL; ATHEROSCLEROTIC PLAQUE; CELL MOTION; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; ATHEROSCLEROSIS; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; INFLAMMATION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLAQUE, ATHEROSCLEROTIC;

EID: 84927640251     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12466     Document Type: Review

References (219)

1. Abbott, K.L., Loss, J.R. II, Robida, A.M. & Murphy, T.J. 2000. Evidence that Galpha(q)-coupled receptor-induced interleukin-6 mRNA in vascular smooth muscle cells involves the nuclear factor of activated T cells. Mol Pharmacol 58, 946-953.
2. Albinsson, S. & Sessa, W.C. 2011. Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury? Physiol Genomics 43, 529-533.
3. Anderson, H.C. 2003. Matrix vesicles and calcification. Curr Rheumatol Rep 5, 222-226.
4. Anderson, H.C., Garimella, R. & Tague, S.E. 2005. The role of matrix vesicles in growth plate development and biomineralization. Front Biosci 10, 822-837.
5. Andreeva, E.R., Pugach, I.M. & Orekhov, A.N. 1997. Subendothelial smooth muscle cells of human aorta express macrophage antigen insitu and invitro. Atherosclerosis 135, 19-27.
6. Aoyama, T., Chen, M., Fujiwara, H., Masaki, T. & Sawamura, T. 2000. LOX 1 mediates lysophosphatidylcholine-induced oxidized LDL uptake insmooth muscle cells. FEBS Lett 467, 217-220.
7. Asada, H., Paszkowiak, J., Teso, D., Alvi, K., Thorisson, A., Frattini, J.C., Kudo, F.A., Sumpio, B.E. & Dardik, A. 2005. Sustained orbital shear stress stimulates smooth muscle cell proliferation via the extracellular signal-regulated protein kinase 1/2 pathway. J Vasc Surg 42, 772-780.
8. Athyros, V.G., Katsiki, N., Karagiannis, A. & Mikhailidis, D.P. 2014. Combination of statin plus renin angiotensin system inhibition for the prevention or the treatment of atherosclerotic cardiovascular disease. Curr Pharm Des 20, 6299-6305.
9. Babaev, V.R., Bobryshev, Y.V., Stenina, O.V., Tararak, E.M. & Gabbiani, G. 1990. Heterogeneity of smooth muscle cells in atheromatous plaque of human aorta. Am J Pathol 136, 1031-1042.
10. Babaev, V.R., Bobryshev, Y.V., Sukhova, G.K. & Kasantseva, I.A. 1993. Monocyte/macrophage accumulation and smooth muscle cell phenotypes in early atherosclerotic lesions of human aorta. Atherosclerosis 100, 237-248.
11. Barnes, M.J. & Farndale, R.W. 1999. Collagens and atherosclerosis. Exp Gerontol 34, 513-525.
12. Bear, M., Butcher, M. & Shaughnessy, S.G. 2008. Oxidized low-density lipoprotein acts synergistically with beta-glycerophosphate to induce osteoblast differentiation in primary cultures of vascular smooth muscle cells. J Cell Biochem 105, 185-193.
13. Bentzon, J.F., Weile, C., Sondergaard, C.S., Hindkjaer, J., Kassem, M. & Falk, E. 2006. Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol 26, 2696-2702.
14. Bentzon, J.F., Sondergaard, C.S., Kassem, M. & Falk, E. 2007. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation 116, 2053-2061.
15. Bobryshev, Y.V. 2005. Transdifferentiation of smooth muscle cells into chondrocytes in atherosclerotic arteries insitu: implications for diffuse intimal calcification. J Pathol 205, 641-650.
16. Bobryshev, Y.V. & Lord, R.S. 1996. Langhans cells of human arterial intima: uniform by stellate appearance but different by nature. Tissue Cell 28, 177-194.
17. Bobryshev, Y.V., Lord, R.S. & Warren, B.A. 1995. Calcified deposit formation in intimal thickenings of the human aorta. Atherosclerosis 118, 9-21.
18. Bobryshev, Y.V., Killingsworth, M.C., Huynh, T.G., Lord, R.S., Grabs, A.J. & Valenzuela, S.M. 2007. Are calcifying matrix vesicles in atherosclerotic lesions of cellular origin? Basic Res Cardiol 102, 133-143.
19. Bobryshev, Y.V., Killingsworth, M.C., Lord, R.S. & Grabs, A.J. 2008a. Matrix vesicles in the fibrous cap of atherosclerotic plaque: possible contribution to plaque rupture. JCell Mol Med 12, 2073-2082.
20. Bobryshev, Y.V., Killingsworth, M.C. & Lord, R.S. 2008b. Spatial distribution of osteoblast-specific transcription factor Cbfa1 and bone formation in atherosclerotic arteries. Cell Tissue Res 333, 225-235.
21. Bobryshev, Y.V., Orekhov, A.N., Sobenin, I. & Chistiakov, D.A. 2014. Role of bone-type tissue-nonspecific alkaline phosphatase and PHOSPO1 in vascular calcification. Curr Pharm Des 20, 5821-5828.
22. Bond, M., Chase, A.J., Baker, A.H. & Newby, A.C. 2001. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res 50, 556-565.
23. Bourcier, T., Sukhova, G. & Libby, P. 1997. The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells invitro and in human atherosclerosis. J Biol Chem 272, 15817-15824.
24. Bours, V., Franzoso, G., Brown, K., Park, S., Azarenko, V., Tomita-Yamaguchi, M., Kelly, K. & Siebenlist, U. 1992. Lymphocyte activation and the family of NF-kappa B transcription factor complexes. Curr Top Microbiol Immunol 182, 411-420.
25. Bracey, N.A., Beck, P.L., Muruve, D.A., Hirota, S.A., Guo, J., Jabagi, H., Wright, J.R. Jr, Macdonald, J.A., Lees-Miller, J.P., Roach, D., Semeniuk, L.M. & Duff, H.J. 2013. The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin- 1beta. Exp Physiol 98, 462-472.
26. Brett, J., Schmidt, A.M., Yan, S.D., Zou, Y.S., Weidman, E., Pinsky, D., Nowygrod, R., Neeper, M., Przysiecki, C., Shaw, A., Migheli, A. & Stern, D. 1993. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143, 1699-1712.
27. Broggi, A. & Granucci, F. 2015. Microbe and danger-induced inflammation. Mol Immunol 63, 127-133.
28. Byon, C.H., Javed, A., Dai, Q., Kappes, J.C., Clemens, T.L., Darley-Usmar, V.M., McDonald, J.M. & Chen, Y. 2008. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem 283, 15319-15327.
29. Cai, Q., Lanting, L. & Natarajan, R. 2004. Growth factors induce monocyte binding to vascular smooth muscle cells: implications for monocyte retention in atherosclerosis. Am J Physiol Cell Physiol 287, C707-C714.
30. Cao, S., Zhang, X., Edwards, J.P. & Mosser, D.M. 2006. NF-κB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J Biol Chem 281, 26041-26050.
31. Caplice, N.M., Bunch, T.J., Stalboerger, P.G., Wang, S., Simper, D., Miller, D.V., Russell, S.J., Litzow, M.R. & Edwards, W.D. 2003. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci USA 100, 4754-4759.
32. Cascella, T., Radhakrishnan, Y., Maile, L.A., Busby, W.H. Jr, Gollahon, K., Colao, A. & Clemmons, D.R. 2010. Aldosterone enhances IGF-I-mediated signaling and biological function in vascular smooth muscle cells. Endocrinology 151, 5851-5864.
33. Cercek, B., Yamashita, M., Dimayuga, P., Zhu, J., Fishbein, M.C., Kaul, S., Shah, P.K., Nilsson, J. & Regnstrom, J. 1997. Nuclear factor-kappaB activity and arterial response to balloon injury. Atherosclerosis 131, 59-66.
34. Chen, J., Kitchen, C.M., Streb, J.W. & Miano, J.M. 2002. Myocardin: a component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol 34, 1345-1356.
35. Chen, L., Frister, A., Wang, S., Ludwig, A., Behr, H., Pippig, S., Li, B., Simm, A., Hofmann, B., Pilowski, C., Koch, S., Buerke, M., Rose-John, S., Werdan, K. & Loppnow, H. 2009a. Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production. Am J Physiol Heart Circ Physiol 296, H987-H996.
36. Chen, Y.J., Wei, Y.Y., Chen, H.T., Fong, Y.C., Hsu, C.J., Tsai, C.H., Hsu, H.C., Liu, S.H. & Tang, C.H. 2009b. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, Erk, and NF-kappaB-dependent pathway in human chondrosarcoma cells. J Cell Physiol 221, 98-108.
37. Chen, Q., Jin, M., Yang, F., Zhu, J., Xiao, Q. & Zhang, L. 2013. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm 2013, 928315.
38. Cherepanova, O.A., Pidkovka, N.A., Yoshida, T., Gan, Q., Adiguzel, E., Bendeck, M.P., Berliner, J., Leitinger, N. & Owens, G.K. 2009. Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration. Circ Res 104, 609-618.
39. Chistiakov, D.A., Sobenin, I.A., Orekhov, A.N. & Bobryshev, Y.V. 2014. Human miR-221/222 in physiological and atherosclerotic vascular remodeling. Biomed Res Int 2014, 354517.
40. Clarke, M. & Bennett, M. 2006. The emerging role of vascular smooth muscle cell apoptosis in atherosclerosis and plaque stability. Am J Nephrol 26, 531-535.
41. Clarke, M.C., Figg, N., Maguire, J.J., Davenport, A.P., Goddard, M., Littlewood, T.D. & Bennett, M.R. 2006. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 12, 1075-1080.
42. Clarke, M.C., Littlewood, T.D., Figg, N., Maguire, J.J., Davenport, A.P., Goddard, M. & Bennett, M.R. 2008. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ Res 102, 1529-1538.
43. Clarke, M.C., Talib, S., Figg, N.L. & Bennett, M.R. 2010. Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis. Circ Res 106, 363-372.
44. Cole, J.E., Georgiou, E. & Monaco, C. 2010. The expression and functions of toll-like receptors in atherosclerosis. Mediators Inflamm 2010, 393946.
45. Corjay, M.H., Diamond, S.M., Schlingmann, K.L., Gibbs, S.K., Stoltenborg, J.K. & Racanelli, A.L. 1999. Alphavbeta3, alphavbeta5, and osteopontin are coordinately upregulated at early time points in a rabbit model of neointima formation. J Cell Biochem 75, 492-504.
46. Couffinhal, T., Duplàa, C., Moreau, C., Lamazière, J.M. & Bonnet, J. 1994. Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ Res 74, 225-234.
47. Cuff, C.A., Kothapalli, D., Azonobi, I., Chun, S., Zhang, Y., Belkin, R., Yeh, C., Secreto, A., Assoian, R.K., Rader, D.J. & Puré, E. 2001. The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J Clin Invest 108, 1031-1040.
48. Cui, Y., Sun, Y.W., Lin, H.S., Su, W.M., Fang, Y., Zhao, Y., Wei, X.Q., Qin, Y.H., Kohama, K. & Gao, Y. 2014. Platelet-derived growth factor-BB induces matrix metalloproteinase-2 expression and rat vascular smooth muscle cell migration via ROCK and ERK/p38 MAPK pathways. Mol Cell Biochem 393, 255-263.
49. Curtiss, L.K. & Tobias, P.S. 2009. Emerging role of Toll-like receptors in atherosclerosis. J Lipid Res 50(Suppl), S340-S345.
50. Dab, H., Kacem, K., Hachani, R., Dhaouadi, N., Hodroj, W., Sakly, M., Randon, J. & Bricca, G. 2012a. Physiological regulation of extracellular matrix collagen and elastin in the arterial wall of rats by noradrenergic tone and angiotensin II. J Renin Angiotensin Aldosterone Syst 13, 19-28.
51. Dab, H., Hachani, R., Dhaouadi, N., Hodroj, W., Sakly, M., Randon, J., Bricca, G. & Kacem, K. 2012b. Physiological regulation of MMPs and tPA/PAI in the arterial wall of rats by noradrenergic tone and angiotensin II. J Renin Angiotensin Aldosterone Syst 13, 36-45.
52. Dai, Y., Mercanti, F., Dai, D., Wang, X., Ding, Z., Pothineni, N.V. & Mehta, J.L. 2013. LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells. Biochem Biophys Res Commun 437, 62-66.
53. Dandré, F. & Owens, G.K. 2004. Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes. Am J Physiol Heart Circ Physiol 286, H2042-H2051.
54. Daniel, J.M., Bielenberg, W., Stieger, P., Weinert, S., Tillmans, H. & Sedding, D.G. 2010. Time-course analysis on the differentiation of bone marrow-derived progenitor cells into smooth muscle cells during neointima formation. Arterioscler Thromb Vasc Biol 30, 1890-1896.
55. Darvin, P., Joung, Y.H. & Yang, Y.M. 2013. JAK2-STAT5B pathway and osteoblast differentiation. JAKSTAT 2, e24931.
56. Davies, P.F., Civelek, M., Fang, Y., Guerraty, M.A. & Passerini, A.G. 2010. Endothelial heterogeneity associated withregional atherosusceptibility and adaptation to disturbed blood flow invivo. Semin Thromb Hemost 36, 265-275.
57. Davies, P.F., Civelek, M., Fang, Y. & Fleming, I. 2013. The atherosusceptible endothelium: endothelial phenotypes in complex haemodynamic shear stress regions invivo. Cardiovasc Res 99, 315-327.
58. Davis, B.N., Hilyard, A.C., Nguyen, P.H., Lagna, G. & Hata, A. 2009. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 284, 3728-3738.
59. De Graaf, R., Kloppenburg, G., Kitslaar, P.J., Bruggeman, C.A. & Stassen, F. 2006. Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4. Microbes Infect 8, 1859-1865.
60. Deaton, R.A., Gan, Q. & Owens, G.K. 2009. Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. Am J Physiol Heart Circ Physiol 296, H1027-H1037.
61. Deiuliis, J., Mihai, G., Zhang, J., Taslim, C., Varghese, J.J., Maiseyeu, A., Huang, K. & Rajagopalan, S. 2014. Renin-sensitive microRNAs correlate with atherosclerosis plaque progression. J Hum Hypertens 28, 251-258.
62. Dorweiler, B., Torzewski, M., Dahm, M., Kirkpatrick, C.J., Lackner, K.J. & Vahl, C.F. 2008. Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima. Thromb Haemost 99, 373-381.
63. Eto, H., Miyata, M., Kume, N., Minami, M., Itabe, H., Orihara, K., Hamasaki, S., Biro, S., Otsuji, Y., Kita, T. & Tei, C. 2006. Expression of lectin-like oxidized LDL receptor-1 in smooth muscle cells after vascular injury. Biochem Biophys Res Commun 341, 591-598.
64. Fan, L. & Karino, T. 2010. Effect of a disturbed flow on proliferation of the cells of a hybrid vascular graft. Biorheology 47, 31-38.
65. Fan, L., Sakai, J., Bessho, S., Wada, S. & Karino, T. 2010. Effect of a disturbed flow on adhesion of monocytes to a model of an arterial wall. Biorheology 47, 15-29.
66. Ferrario, C.M. 2006. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. J Renin Angiotensin Aldosterone Syst 7, 3-14.
67. Finsen, A.V., Lunde, I.G., Sjaastad, I., Østli, E.K., Lyngra, M., Jarstadmarken, H.O., Hasic, A., Nygård, S., Wilcox-Adelman, S.A., Goetinck, P.F. etal. 2011. Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathway. PLoS One 6, e28302.
68. Fischer, C., Schneider, M. & Carmeliet, P. 2006. Principles and therapeutic implications of angiogenesis, vasculogenesis and arteriogenesis. Handb Exp Pharmacol 176, 157-212.
69. Fisk, M., Gajendragadkar, P.R., Mäki-Petäjä, K.M., Wilkinson, I.B. & Cheriyan, J. 2014. Therapeutic potential of p38 MAP kinase inhibition in the management of cardiovascular disease. Am J Cardiovasc Drugs 14, 155-165.
70. Fitzgerald, T.N., Shepherd, B.R., Asada, H., Teso, D., Muto, A., Fancher, T., Pimiento, J.M., Maloney, S.P. & Dardik, A. 2008. Laminar shear stress stimulates vascular smooth muscle cell apoptosis via the Akt pathway. J Cell Physiol 216, 389-395.
71. Franco, C.D., Hou, G. & Bendeck, M.P. 2002. Collagens, integrins, and the discoidin domain receptors in arterial occlusive disease. Trends Cardiovasc Med 12, 143-148.
72. Furgeson, S.B., Simpson, P.A., Park, I., Vanputten, V., Horita, H., Kontos, C.D., Nemenoff, R.A. & Weiser-Evans, M.C. 2010. Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation. Cardiovasc Res 86, 274-282.
73. Gambillara, V., Thacher, T., Silacci, P. & Stergiopulos, N. 2008. Effects of reduced cyclic stretch on vascular smooth muscle cell function of pig carotids perfused exvivo. Am J Hypertens 21, 425-431.
74. Garanich, J.S., Pahakis, M. & Tarbell, J.M. 2005. Shear stress inhibits smooth muscle cell migration via nitric oxide-mediated downregulation of matrix metalloproteinase-2 activity. Am J Physiol Heart Circ Physiol 288, H2244-H2252.
75. George, S.J. 2000. Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis. Expert Opin Investig Drugs 9, 993-1007.
76. Goldman, J., Zhong, L. & Liu, S.Q. 2007. Negative regulation of vascular smooth muscle cell migration by blood shear stress. Am J Physiol Heart Circ Physiol 292, H928-H938.
77. Gomez, D. & Owens, G.K. 2012. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 95, 156-164.
78. Guo, Y.S., Wu, Z.G., Yang, J.K. & Chen, X.J. 2015. Impact of losartan and angiotensin II on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat vascular smooth muscle cells. Mol Med Rep 11, 1587-1594.
79. Haga, M., Yamashita, A., Paszkowiak, J., Sumpio, B.E. & Dardik, A. 2003. Oscillatory shear stress increases smooth muscle cell proliferation and Akt phosphorylation. J Vasc Surg 37, 1277-1284.
80. Hastings, N.E., Simmers, M.B., McDonald, O.G., Wamhoff, B.R. & Blackman, B.R. 2007. Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming. Am J Physiol Cell Physiol 293, C1824-C1833.
81. Hastings, N.E., Feaver, R.E., Lee, M.Y., Wamhoff, B.R. & Blackman, B.R. 2009. Human IL-8 regulates smooth muscle cell VCAM-1 expression in response to endothelial cells exposed to atheroprone flow. Arterioscler Thromb Vasc Biol 29, 725-731.
82. Hayakawa, E., Yoshimoto, T., Sekizawa, N., Sigiyama, T. & Hirata, Y. 2012. Overexpression of receptor for advanced glycation end products induces monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cell line. J Atheroscler Thromb 19, 13-22.
83. Heino, J. 2000. The collagen receptor integrins have distinct ligand recognition and signaling functions. Matrix Biol 19, 319-323.
84. Heizmann, C.W., Ackermann, G.E. & Galichet, A. 2007. Pathologies involving the S100 proteins and RAGE. Subcell Biochem. 45, 93-138.
85. Herman, M.P., Sukhova, G.K., Kisiel, W., Foster, D., Kehry, M.R., Libby, P. & Schönbeck, U. 2001. Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J Clin Invest 107, 1117-1126.
86. Hou, G., Vogel, W.F. & Bendeck, M.P. 2002. Tyrosine kinase activity of discoidin domain receptor 1 is necessary for smooth muscle cell migration and matrix metalloproteinase expression. Circ Res 90, 1147-1149.
87. Ikesue, M., Matsui, Y., Ohta, D., Danzaki, K., Ito, K., Kanayama, M., Kurotaki, D., Morimoto, J., Kojima, T., Tsutsui, H. & Uede, T. 2011. Syndecan-4 deficiency limits neointimal formation after vascular injury by regulating vascular smooth muscle cell proliferation and vascular progenitor cell mobilization. Arterioscler Thromb Vasc Biol 31, 1066-1074.
88. Iwata, H., Manabe, I., Fujiu, K., Yamamoto, T., Takeda, N., Eguchi, K., Furuya, A., Kuro-o, M., Sata, M. & Nagai, R. 2010. Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth muscle cell lineages. Circulation 122, 2048-2057.
89. Jaulmes, A., Thierry, S., Janvier, B., Raymondjean, M. & Marechal, V. 2006. Activation of sPLA2-IIA and PGE2production by high mobility group protein B1 in vascularsmooth muscle cells sensitized by IL-1beta. FASEB J 20, 1727-1729.
90. Jiang, J., Chan, Y.S., Loh, Y.H., Cai, J., Tong, G.Q., Lim, C.A., Robson, P., Zhong, S. & Ng, H.H. 2008. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 10, 353-360.
91. Jin, W., Reddy, M.A., Chen, Z., Putta, S., Lanting, L., Kato, M., Park, J.T., Chandra, M., Wang, C., Tangirala, R.K. & Natarajan, R. 2012. Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells. J Biol Chem 287, 15672-15683.
92. Johnson, J.L. 2014. Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis. Cardiovasc Res 103, 452-460.
93. Johnson, K., Polewski, M. & Terkeltaub, R.A. 2008. Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. Circ Res 102, 529-537.
94. Kappert, K., Blaschke, F., Meehan, W.P., Kawano, H., Grill, M., Fleck, E., Hsueh, W.A., Law, R.E. & Graf, K. 2001. Integrins alphavbeta3 and alphavbeta5 mediate VSMC migration and are elevated during neointima formation in the rat aorta. Basic Res Cardiol 96, 42-49.
95. Karwowski, W., Naumnik, B., Szczepański, M. & Myśliwiec, M. 2012. The mechanism of vascular calcification - a systematic review. Med Sci Monit 18, RA1-RA11.
96. Kataoka, H., Kume, N., Miyamoto, S., Minami, M., Morimoto, M., Hayashida, K., Hashimoto, N. & Kita, T. 2001. Oxidized LDL modulates Bax/Bcl-2 through the lectin-like Ox-LDL receptor-1 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21, 955-960.
97. Kawahito, H., Yamada, H., Irie, D., Kato, T., Akakabe, Y., Kishida, S., Takata, H., Wakana, N., Ogata, T., Ikeda, K., Ueyama, T., Matoba, S., Mori, Y. & Matsubara, H. 2013. Periaortic adipose tissue-specific activation of the renin-angiotensin system contributes to atherosclerosis development in uninephrectomized apoE-/- mice. Am J Physiol Heart Circ Physiol 305, H667-H675.
98. Kiani, C., Chen, L., Wu, Y.J., Yee, A.J. & Yang, B.B. 2002. Structure and function of aggrecan. Cell Res 12, 19-32.
99. Kiffer-Moreira, T. & Narisawa, S. 2013. The use of tissue-nonspecific alkaline phosphatase (TNAP) and PHOSPHO1 inhibitors to affect mineralization by cultured cells. Methods Mol Biol 1053, 125-134.
100. Kim, H.Y., Kang, Y.J., Song, I.H., Choi, H.C. & Kim, H.S. 2008. Upregulation of interleukin-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertens Res 31, 515-523.
101. Koide, S., Okazaki, M., Tamura, M., Ozumi, K., Takatsu, H., Kamezaki, F., Tanimoto, A., Tasaki, H., Sasaguri, Y., Nakashima, Y. & Otsuji, Y. 2007. PTEN reduces cuff-induced neointima formation and proinflammatory cytokines. Am J Physiol Heart Circ Physiol 292, H2824-H2831.
102. Koyama, H., Raines, E.W., Bornfeldt, K.E., Roberts, J.M. & Ross, R. 1996. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 87, 1069-1078.
103. Kunz, J. 2007. Matrix metalloproteinases and atherogenesis in dependence of age. Gerontology 53, 63-73.
104. Landry, D.B., Couper, L.L., Bryant, S.R. & Lindner, V. 1997. Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1. Am J Pathol 151, 1085-1095.
105. Lee, M.Y. & Lai, W.T. 2014. Plasma renin level and aldosterone to renin ratio are associated with presence of carotid plaques in patients with stable coronary artery disease. J Renin Angiotensin Aldosterone Syst pii: 1470320314548743.[Epub ahead of print].
106. Lee, C.W., Lin, W.N., Lin, C.C., Luo, S.F., Wang, J.S., Pouyssegur, J. & Yang, C.M. 2006a. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation. J Cell Physiol 207, 174-186.
107. Lee, J.S., Yu, Q., Shin, J.T., Sebzda, E., Bertozzi, C., Chen, M., Mericko, P., Stadtfield, M., Zhou, D., Cheng, L. etal. 2006b. Klf2 is an essential regulator of vascular hemodynamic forces invivo. Dev Cell 11, 845-857.
108. Lee, G.L., Chang, Y.W., Wu, J.Y., Wu, M.L., Wu, K.K., Yet, S.F. & Kuo, C.C. 2012. TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production. Arterioscler Thromb Vasc Biol 32, 2751-2760.
109. Lee, D., Lee, K.H., Park, H., Kim, S.H., Jin, T., Cho, S., Chung, J.H., Lim, S. & Park, S. 2013a. The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice. PLoS One 8, e69669.
110. Lee, J.H., Joo, J.H., Kim, J., Lim, H.J., Kim, S., Curtiss, L., Seong, J.K., Cui, W., Yabe-Nishimura, C. & Bae, Y.S. 2013b. Interaction of NADPH oxidase 1 with Toll-like receptor 2 induces migration of smooth muscle cells. Cardiovasc Res 99, 483-493.
111. di Leva, G., Gasparini, P., Piovan, C., Ngankeu, A., Garofalo, M., Taccioli, C., Iorio, M.V., Li, M., Volinia, S., Alder, H., Nakamura, T., Nuovo, G., Liu, Y., Nephew, K.P. & Croce, C.M. 2010. MicroRNA cluster 221-222 and estrogen receptor α interactions in breast cancer. J Natl Cancer Inst 102, 706-721.
112. Li, X., Yang, H.Y. & Giachelli, C.M. 2006. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 98, 905-912.
113. Li, X., Yang, H.Y. & Giachelli, C.M. 2008. BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 199, 271-277.
114. Li, H., Xu, H. & Sun, B. 2012. Lipopolysaccharide regulates MMP-9 expression through TLR4/NF-κB signaling in human arterial smooth muscle cells. Mol Med Rep 6, 774-778.
115. 3 dopamine receptor on migration of vascular smooth muscle cells induced by synergistic effect of angiotensin II and aldosterone. Clin Exp Hypertens [Epub ahead of print].
116. Liang, K.C., Lee, C.W., Lin, W.N., Lin, C.C., Wu, C.B., Luo, S.F. & Yang, C.M. 2007. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells. J Cell Physiol 211, 759-770.
117. Lin, C.C., Tseng, H.W., Hsieh, H.L., Lee, C.W., Wu, C.Y., Cheng, C.Y. & Yang, C.M. 2008. Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells. Toxicol Appl Pharmacol 229, 386-398.
118. Lin, J., Kakkar, V. & Lu, X. 2014. Impact of matrix metalloproteinases on atherosclerosis. Curr Drug Targets 15, 442-453.
119. Liu, S.Q., Tieche, C., Tang, D. & Alkema, P. 2003. Pattern formation of vascular smooth muscle cells subject to nonuniform fluid shear stress: role of PDGF-beta receptor and Src. Am J Physiol Heart Circ Physiol 285, H1081-H1090.
120. Liu, Z., Dronadula, N. & Rao, G.N. 2004. A novel role for nuclear factor of activated T cells in receptor tyrosine kinase and G protein-coupled receptor agonist-induced vascular smooth muscle cell motility. J Biol Chem 279, 41218-41226.
121. Liu, Y., Sinha, S., McDonald, O.G., Shang, Y., Hoofnagle, M.H. & Owens, G.K. 2005. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem 280, 9719-9727.
122. Liu, X., Cheng, Y., Zhang, S., Lin, Y., Yang, J. & Zhang, C. 2009. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104, 476-487.
123. Liu, G., Hitomi, H., Hosomi, N., Lei, B., Nakano, D., Deguchi, K., Mori, H., Masaki, T., Ma, H., Griendling, K.K. & Nishiyama, A. 2011. Mechanical stretch augments insulin-induced vascular smooth muscle cell proliferation by insulin-like growth factor-1 receptor. Exp Cell Res 317, 2420-2428.
124. Liu, J., Ren, Y., Kang, L. & Zhang, L. 2014a. Oxidized low-density lipoprotein increases the proliferation and migration of human coronary artery smooth muscle cells through the upregulation of osteopontin. Int J Mol Med 33, 1341-1347.
125. Liu, Y., Yin, H., Zhao, M. & Lu, Q. 2014b. TLR2 and TLR4 in autoimmune diseases: a comprehensive review. Clin Rev Allergy Immunol 47, 136-147.
126. Loh, C., Shaw, K.T., Carew, J., Viola, J.P., Luo, C., Perrino, B.A. & Rao, A. 1996. Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J Biol Chem 271, 10884-10891.
127. London, G.M., Marchais, S.J., Guérin, A.P. & Métivier, F. 2005. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens 14, 525-531.
128. Lu, K.K., Trcka, D. & Bendeck, M.P. 2011. Collagen stimulates discoidin domain receptor 1-mediated migration of smooth muscle cells through Src. Cardiovasc Pathol 20, 71-76.
129. Magne, D., Julien, M., Vinatier, C., Merhi-Soussi, F., Weiss, P. & Guicheux, J. 2005. Cartilage formation in growth plate and arteries: from physiology to pathology. BioEssays 27, 708-716.
130. Malek, A.M., Alper, S.L. & Izumo, S. 1999. Hemodynamic shear stress and its role in atherosclerosis. JAMA 282, 2035-2042.
131. Martin, K., Weiss, S., Metharom, P., Schmeckpeper, J., Hynes, B., O'Sullivan, J. & Caplice, N. 2009. Thrombin stimulates smooth muscle cell differentiation from peripheral blood mononuclear cells via protease-activated receptor-1, RhoA, and myocardin. Circ Res 105, 214-218.
132. Mayr, M., Hu, Y., Hainaut, H. & Xu, Q. 2002. Mechanical stress-induced DNA damage and rac-p38MAPK signal pathways mediate p53-dependent apoptosis in vascular smooth muscle cells. FASEB J 16, 1423-1425.
133. Mazak, I., Fiebeler, A., Muller, D.N., Park, J.K., Shagdarsuren, E., Lindschau, C., Dechend, R., Viedt, C., Pilz, B., Haller, H. & Luft, F.C. 2004. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation 109, 2792-2800.
134. Mazière, C., Salle, V., Gomila, C. & Mazière, J.C. 2013. Oxidized low density lipoprotein increases RANKL level in human vascular cells. Involvement of oxidative stress. Biochem Biophys Res Commun 440, 295-299.
135. McCormick, M.M., Rahimi, F., Bobryshev, Y.V., Gaus, K., Zreiqat, H., Cai, H., Lord, R.S. & Geczy, C.L. 2005. S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. J Biol Chem 280, 41521-41529.
136. McGraw, A.P., Bagley, J., Chen, W.S., Galayda, C., Nickerson, H., Armani, A., Caprio, M., Carmeliet, P. & Jaffe, I.Z. 2013. Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism. J Am Heart Assoc 2, e000018.
137. Mehta, J.L., Chen, J., Hermonat, P.L., Romeo, F. & Novelli, G. 2006. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 69, 36-45.
138. Mehta, J.L., Sanada, N., Hu, C.P., Chen, J., Dandapat, A., Sugawara, F., Satoh, H., Inoue, K., Kawase, Y., Jishage, K. etal. 2007. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res 100, 1634-1642.
139. Min, L.J., Mogi, M., Tamura, K., Iwanami, J., Sakata, A., Fujita, T., Tsukuda, K., Jing, F., Iwai, M. & Horiuchi, M. 2009. Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway. J Mol Cell Cardiol 47, 798-809.
140. Minami, T., Miura, M., Aird, W.C. & Kodama, T. 2006. Thrombin-induced autoinhibitory factor, Down syndrome critical region-1, attenuates NFAT-dependent vascular cell adhesion molecule-1 expression and inflammation in the endothelium. J Biol Chem 281, 20503-20520.
141. Moiseeva, E.P. 2001. Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovasc Res 52, 372-386.
142. Molossi, S., Clausell, N. & Rabinovitch, M. 1995. Reciprocal induction of tumor necrosis factor-alpha and interleukin-1 beta activity mediates fibronectin synthesis in coronary artery smooth muscle cells. J Cell Physiol 163, 19-29.
143. Moon, S.K., Kim, H.M. & Kim, C.H. 2004. PTEN induces G1 cell cycle arrest and inhibits MMP-9 expression via the regulation of NF-kappaB and AP-1 in vascular smooth muscle cells. Arch Biochem Biophys 421, 267-276.
144. Morrow, D., Sweeney, C., Birney, Y.A., Cummins, P.M., Walls, D., Redmond, E.M. & Cahill, P.A. 2005. Cyclic strain inhibits Notch receptor signaling in vascular smooth muscle cells invitro. Circ Res 96, 567-575.
145. Nakahara, T., Sato, H., Shimizu, T., Tanaka, T., Matsui, H., Kawai-Kowase, K., Sato, M., Iso, T., Arai, M. & Kurabayashi, M. 2010. Fibroblast growth factor-2 induces osteogenic differentiation through a Runx2 activation in vascular smooth muscle cells. Biochem Biophys Res Commun 394, 243-248.
146. Nakano-Kurimoto, R., Ikeda, K., Uraoka, M., Nakagawa, Y., Yutaka, K., Koide, M., Takahashi, T., Matoba, S., Yamada, H., Okigaki, M. & Matsubara, H. 2009. Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition. Am J Physiol Heart Circ Physiol 297, H1673-H1684.
147. Nemenoff, R.A., Horita, H., Ostriker, A.C., Furgeson, S.B., Simpson, P.A., VanPutten, V., Crossno, J., Offermanns, S. & Weiser-Evans, M.C. 2011. SDF-1α induction in mature smooth muscle cells by inactivation of PTEN is a critical mediator of exacerbated injury-induced neointima formation. Arterioscler Thromb Vasc Biol 31, 1300-1308.
148. Nguyen Dinh Cat, A. & Touyz, R.M. 2011. A new look at the renin-angiotensin system - focusing on the vascular system. Peptides 32, 2141-2150.
149. Nilsson, L.M., Nilsson-Ohman, J., Zetterqvist, A.V. & Gomez, M.F. 2008. Nuclear factor of activated T-cells transcription factors in the vasculature: the good guys or the bad guys? Curr Opin Lipidol 19, 483-490.
150. Orbe, J., Fernandez, L., Rodríguez, J.A., Rábago, G., Belzunce, M., Monasterio, A., Roncal, C. & Páramo, J.A. 2003. Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed. Atherosclerosis 170, 269-276.
151. Orr, A.W., Lee, M.Y., Lemmon, J.A., Yurdagul, A. Jr, Gomez, M.F., Bortz, P.D. & Wamhoff, B.R. 2009. Molecular mechanisms of collagen isotype-specific modulation of smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 29, 225-231.
152. Owens, G.K., Kumar, M.S. & Wamhoff, B.R. 2004. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84, 767-801.
153. Pacurari, M., Kafoury, R., Tchounwou, P.B. & Ndebele, K. 2014. The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling. Int J Inflam 2014, 689360.
154. Palumbo, R., Gaetano, C., Melillo, G., Toschi, E., Remuzzi, A. & Capogrossi, M.C. 2000. Shear stress downregulation of platelet-derived growth factor receptor-β and matrix metalloprotease-2 is associated with inhibition of smooth muscle cell invasion and migration. Circulation 102, 225-230.
155. Pan, C.H., Chen, C.W., Sheu, M.J. & Wu, C.H. 2012. Salvianolic acid B inhibits SDF-1α-stimulated cell proliferation and migration of vascular smooth muscle cells by suppressing CXCR4 receptor. Vascul Pharmacol 56, 98-105.
156. Pape, R., Rauch, B.H., Rosenkranz, A.C., Kaber, G. & Schrör, K. 2008. Transcriptional inhibition of protease-activated receptor-1 expression by prostacyclin in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 28, 534-540.
157. Park, W.K., Regoli, D. & Rioux, F. 1973. Characterization of angiotensin receptors in vascular and intestinal smooth muscles. Br J Pharmacol 48, 288-301.
158. Park, J.K., Fischer, R., Dechend, R., Shagdarsuren, E., Gapeljuk, A., Wellner, M., Meiners, S., Gratze, P., Al-Saadi, N., Feldt, S. etal. 2007. p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage. Hypertension 49, 481-489.
159. Pedersen, T.X., Madsen, M., Junker, N., Christoffersen, C., Vikeså, J., Bro, S., Hultgårdh-Nilsson, A. & Nielsen, L.B. 2013. Osteopontin deficiency dampens the pro-atherogenic effect of uraemia. Cardiovasc Res 98, 352-359.
160. Perry, R.L. & Rudnick, M.A. 2000. Molecular mechanisms regulating myogenic determination and differentiation. Front Biosci 5, D750-D767.
161. Pirillo, A., Norata, G.D. & Catapano, A.L. 2013. LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm 2013, 152786.
162. Qi, Y.X., Jiang, J., Jiang, X.H., Wang, X.D., Ji, S.Y., Han, Y., Long, D.K., Shen, B.R., Yan, Z.Q., Chen, S. & Jiang, Z.L. 2011. PDGF-BB and TGF-beta1 on cross-talk between endothelial and smooth muscle cells in vascular remodeling induced by low shear stress. Proc Natl Acad Sci USA 108, 1908-1913.
163. Qiu, J., Zheng, Y., Hu, J., Liao, D., Gregersen, H., Deng, X., Fan, Y. & Wang, G. 2013. Biomechanical regulation of vascular smooth muscle cell functions: from invitro to invivo understanding. J R Soc Interface 11, 20130852.
164. Qwarnström, E.E., Ostberg, C.O., Turk, G.L., Richardson, C.A. & Bomsztyk, K. 1994. Fibronectin attachment activates the NF-kappa B p50/p65 heterodimer in fibroblasts and smooth muscle cells. J Biol Chem 269, 30765-30768.
165. Raffetto, J.D. & Khalil, R.A. 2008. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 75, 346-359.
166. Rautureau, Y., Paradis, P. & Schiffrin, E.L. 2011. Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells. Steroids 76, 834-839.
167. Regan, C.P., Adam, P.J., Madsen, C.S. & Owens, G.K. 2000. Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. JClin Invest 106, 1139-1147.
168. Reynaud, E.G., Leibovitch, M.P., Tintignac, L.A., Pelpel, K., Guillier, M. & Leibovitch, S.A. 2000. Stabilization of MyoD by direct binding to p57(Kip2). J Biol Chem 275, 18767-18776.
169. Rong, J.X., Shapiro, M., Trogan, E. & Fisher, E.A. 2003. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci USA 100, 13531-13536.
170. Roycik, M.D., Myers, J.S., Newcomer, R.G. & Sang, Q.X. 2013. Matrix metalloproteinase inhibition in atherosclerosis and stroke. Curr Mol Med 13, 1299-1313.
171. Salmon, M., Gomez, D., Greene, E., Shankman, L. & Owens, G.K. 2012. Cooperative binding of KLF4, pELK-1, and HDAC2 to a G/C repressor element in the SM22α promoter mediates transcriptional silencing during SMC phenotypic switching invivo. Circ Res 111, 685-696.
172. Santiago, F.S. & Khachigian, L.M. 2004. Ets-1 stimulates platelet-derived growth factor A-chain gene transcription and vascular smooth muscle cell growth via cooperative interactions with Sp1. Circ Res 95, 479-487.
173. Sarkar, S., Dubaybo, H., Ali, S., Goncalves, P., Kollepara, S.L., Sethi, S., Philip, P.A. & Li, Y. 2013. Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA. Am J Cancer Res 3, 465-477.
174. Sawamura, T., Kume, N., Aoyama, T., Moriwaki, H., Hoshikawa, H., Aiba, Y., Tanaka, T., Miwa, S., Katsura, Y., Kita, S. & Masaki, T. 1997. An endothelial receptor for oxidized low-density lipoprotein. Nature 386, 73-77.
175. Sawamura, T., Wakabayashi, I. & Okamura, T. 2015. LOX-1 in atherosclerotic disease. Clin Chim Acta 440C, 157-163.
176. Schoneveld, A.H., Oude Nijhuis, M.M., van Middelaar, B., Laman, J.D., de Kleijn, D.P. & Pasterkamp, G. 2005. Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development. Cardiovasc Res 66, 162-169.
177. Schulze, P.C., de Keulenaer, G.W., Kassik, K.A., Takahashi, T., Chen, Z., Simon, D.I. & Lee, R.T. 2003. Biomechanically induced gene iex-1 inhibits vascular smooth muscle cell proliferation and neointima formation. Circ Res 93, 1210-1217.
178. Schumacher, C., Clark-Lewis, I., Baggiolini, M. & Moser, B. 1992. High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc Natl Acad Sci USA 89, 10542-10546.
179. Shin, J., Lee, W., Lee, D., Koo, B.K., Han, I., Lim, Y., Woods, A., Couchman, J.R. & Oh, E.S. 2001. Solution structure of the dimeric cytoplasmic domain of syndecan-4. Biochemistry 40, 8471-8478.
180. Siasos, G., Tousoulis, D., Kioufis, S., Oikonomou, E., Siasou, Z., Limperi, M., Papavassiliou, A.G. & Stefanadis, C. 2012. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases. Curr Top Med Chem 12, 1132-1148.
181. Skinner, M.P., Raines, E.W. & Ross, R. 1994. Dynamic expression of alpha 1 beta 1 and alpha 2 beta 1 integrin receptors by human vascular smooth muscle cells. Alpha 2 beta 1 integrin is required for chemotaxis across type I collagen- coated membranes. Am J Pathol 145, 1070-1081.
182. Skripchenko, A., Awatefe, H., Thompson-Montgomery, D., Myrup, A., Turgeon, A. & Wagner, S.J. 2013. An inhibition of p38 mitogen activated protein kinase delays the platelet storage lesion. PLoS One 8, e70732.
183. Steitz, S.A., Speer, M.Y., Curinga, G., Yang, H.Y., Haynes, P., Aebersold, R., Schinke, T., Karsenty, G. & Giachelli, C.M. 2001. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 89, 1147-1154.
184. Stewart, H.J., Guildford, A.L., Lawrence-Watt, D.J. & Santin, M. 2009. Substrate-induced phenotypical change of monocytes/macrophages into myofibroblast-like cells: a new insight into the mechanism of in-stent restenosis. J Biomed Mater Res A 90, 465-471.
185. Suski, M., Gebska, A., Olszanecki, R., Stachowicz, A., Uracz, D., Madej, J. & Korbut, R. 2014. Influence of atorvastatin on angiotensin I metabolism in resting and TNF-α -activated rat vascular smooth muscle cells. J Renin Angiotensin Aldosterone Syst 15, 378-383.
186. Takabe, W., Warabi, E. & Noguchi, N. 2011. Anti-atherogenic effect of laminar shear stress via Nrf2 activation. Antioxid Redox Signal 15, 1415-1426.
187. Tanabe, N., Wheal, B.D., Kwon, J., Chen, H.H., Shugg, R.P., Sims, S.M., Goldberg, H.A. & Dixon, S.J. 2011. Osteopontin signals through calcium and nuclear factor of activated T cells (NFAT) in osteoclasts: a novel RGD-dependent pathway promoting cell survival. J Biol Chem 286, 39871-39881.
188. Tanaka, T., Sato, H., Doi, H., Yoshida, C.A., Shimizu, T., Matsui, H., Yamazaki, M., Akiyama, H., Kawai-Kowase, K., Iso, T., Komori, T., Arai, M. & Kurabayashi, M. 2008. Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells. Mol Cell Biol 28, 1147-1160.
189. Taylor, J., Butcher, M., Zeadin, M., Politano, A. & Shaughnessy, S.G. 2011. Oxidized low-density lipoprotein promotes osteoblast differentiation in primary cultures of vascular smooth muscle cells by up-regulating Osterix expression in an Msx2-dependent manner. J Cell Biochem 112, 581-588.
190. Tyson, K.L., Reynolds, J.L., McNair, R., Zhang, Q., Weissberg, P.L. & Shanahan, C.M. 2003. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 23, 489-494.
191. Ueba, H., Kawakami, M. & Yaginuma, T. 1997. Shear stress as an inhibitor of vascular smooth muscle cell proliferation. Role of transforming growth factor-β1 and tissue-type plasminogen activator. Arterioscler Thromb Vasc Biol 17, 1512-1516.
192. Vanbavel, E. & Bakker, E.N. 2008. A vascular bone collector: arterial calcification requires tissue-type transglutaminase. Circ Res 102, 507-509.
193. Vendrov, A.E., Madamanchi, N.R., Hakim, Z.S., Rojas, M. & Runge, M.S. 2006. Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis. Circ Res 98, 1254-1263.
194. Vendrov, A.E., Madamanchi, N.R., Niu, X.L., Molnar, K.C., Runge, M., Szyndralewiez, C., Page, P. & Runge, M.S. 2010. NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis. J Biol Chem 285, 26545-26557.
195. Wamhoff, B.R., Hoofnagle, M.H., Burns, A., Sinha, S., McDonald, O.G. & Owens, G.K. 2004. A G/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis. Circ Res 95, 981-988.
196. Wang, X., Feuerstein, G.Z., Clark, R.K. & Yue, T.L. 1994. Enhanced leucocyte adhesion to interleukin-1 beta stimulated vascular smooth muscle cells is mainly through intercellular adhesion molecule-1. Cardiovasc Res 28, 1808-1814.
197. Wang, Z., Castresana, M.R., Detmer, K. & Newman, W.H. 2002. An IkappaB-alpha mutant inhibits cytokine gene expression and proliferation in human vascular smooth muscle cells. J Surg Res 102, 198-206.
198. Wang, Z., Wang, D.Z., Pipes, G.C. & Olson, E.N. 2003. Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci USA 100, 7129-7134.
199. Wang, C.C., Lin, W.N., Lee, C.W., Lin, C.C., Luo, S.F., Wang, J.S. & Yang, C.M. 2005. Involvement of p42/p44 MAPK, p38 MAPK, JNK, and NF-kappaB in IL-1beta-induced VCAM-1 expression in human tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 288, L227-L237.
200. Wang, L., Han, Y., Shen, Y., Yan, Z.Q., Zhang, P., Yao, Q.P., Shen, B.R., Cao, L.Z., Qi, Y.X. & Jiang, Z.L. 2014. Endothelial insulin-like growth factor-1 modulates proliferation and phenotype of smooth muscle cells induced by low shear stress. Ann Biomed Eng 42, 776-786.
201. Warabi, E., Takabe, W., Minami, T., Inoue, K., Itoh, K., Yamamoto, M., Ishii, T., Kodama, T. & Noguchi, N. 2007. Shear stress stabilizes NF-E2-related factor 2 and induces antioxidant genes in endothelial cells: role of reactive oxygen/nitrogen species. Free Radic Biol Med 42, 260-269.
202. Wernig, F., Mayr, M. & Xu, Q. 2003. Mechanical stretch-induced apoptosis in smooth muscle cells is mediated by beta1-integrin signaling pathways. Hypertension 41, 903-911.
203. Wright, P.S., Cooper, J.R., Kropp, K.E. & Busch, S.J. 1999. Induction of vascular cell adhesion molecule-1 expression by IL-4 in human aortic smooth muscle cells is not associated with increased nuclear NF-kappaB levels. J Cell Physiol 180, 381-389.
204. Wu, H., Cheng, X.W., Hu, L., Hao, C.N., Hayashi, M., Takeshita, K., Hamrah, M.S., Shi, G.P., Kuzuya, M. & Murohara, T. 2014. Renin inhibition reduces atherosclerotic plaque neovessel formation and regresses advanced atherosclerotic plaques. Atherosclerosis 237, 739-747.
205. Yang, X., Coriolan, D., Murthy, V., Schulz, K., Golenbock, D.T. & Beasley, D. 2005. Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling. Am J Physiol Heart Circ Physiol 289, H1069-H1076.
206. Yellaturu, C.R., Ghosh, S.K., Rao, R.K., Jennings, L.K., Hassid, A. & Rao, G.N. 2002. A potential role for nuclear factor of activated T-cells in receptor tyrosine kinase and G-protein-coupled receptor agonist-induced cell proliferation. Biochem J 368, 183-190.
207. Yin, B.L., Hao, H., Wang, Y.Y., Jiang, Y.J. & Xue, S. 2009. Downregulating osteopontin reduces angiotensin II-induced inflammatory activation in vascular smooth muscle cells. Inflamm Res 58, 67-73.
208. Yoshida, T., Sinha, S., Dandré, F., Wamhoff, B.R., Hoofnagle, M.H., Kremer, B.E., Wang, D.Z., Olson, E.N. & Owens, G.K. 2003. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res 92, 856-864.
209. Yoshida, T., Kaestner, K.H. & Owens, G.K. 2008. Conditional deletion of Kruppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ Res 102, 1548-1557.
210. Yu, J., Li, Y., Li, M., Qu, Z. & Ruan, Q. 2010. Oxidized low density lipoprotein-induced transdifferentiation of bone marrow-derived smooth muscle-like cells into foam-like cells invitro. Int J Exp Pathol 91, 24-33.
211. Yu, H., Clarke, M.C., Figg, N., Littlewood, T.D. & Bennett, M.R. 2011. Smooth muscle cell apoptosis promotes vessel remodeling and repair via activation of cell migration, proliferation, and collagen synthesis. Arterioscler Thromb Vasc Biol 31, 2402-2409.
212. Yu, J., Zhang, Y., Zhang, X., Rudic, R.D., Bauer, P.M., Altieri, D.C. & Sessa, W.C. 2012. Endothelium derived nitric oxide synthase negatively regulates the PDGF-survivin pathway during flow-dependent vascular remodeling. PLoS One 7, e31495.
213. Zampetaki, A., Zhang, Z., Hu, Y. & Xu, Q. 2005. Biomechanical stress induces IL-6 expression in smooth muscle cells via Ras/Rac1-p38 MAPK-NF-kB signaling pathways. Am J Physiol Heart Circ Physiol 288, H2946-H2954.
214. Zhang, Z., Chu, G., Wu, H.X., Zou, N., Sun, B.G. & Dai, Q.Y. 2011. IL-8 reduces VCAM-1 secretion of smooth muscle cells by increasing p-ERK expression when 3-D co-cultured with vascular endothelial cells. Clin Invest Med 34, E138-E146.
215. Zhang, B., Shi, W., Ma, J., Sloan, A., Faul, C., Wei, C., Reiser, J., Yang, Y., Liu, S. & Wang, W. 2012. The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury. J Mol Med (Berl) 90, 1407-1420.
216. Zhao, L., Lee, E., Zukas, A.M., Middleton, M.K., Kinder, M., Acharya, P.S., Hall, J.A., Rader, D.J. & Puré, E. 2008. CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 28, 1283-1289.
217. Zheng, B., Han, M. & Wen, J.K. 2010. Role of Krüppel-like factor 4 in phenotypic switching and proliferation of vascular smooth muscle cells. IUBMB Life 62, 132-139.
218. Zhu, J.H., Chen, C.L., Flavahan, S., Harr, J., Su, B. & Flavahan, N.A. 2011a. Cyclic stretch stimulates vascular smooth muscle cell alignment by redox-dependent activation of Notch3. Am J Physiol Heart Circ Physiol 300, H1770-H1780.
219. Zhu, N., Zhang, D. & Chen, S. 2011b. Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis 215, 286-293.